A new systematic review in The BMJ pooled studies on what happens to weight once people come off weight management drugs.
Recap by typeshit. Post by Facebook on Facebook.
2:21
The Las Vegas station covers Lilly's experimental retatrutide and why researchers see it as a potential step up in weight loss.
Function Health points out that the body produces GLP-1 itself and lists ways it says can boost it. The claims are the company's own.
Popular Mechanics traces how her 1980s work at Mass General showed GLP-1 triggers insulin release. Gallup now puts GLP-1 weight loss use at about 11% of Americans.
32:59
Tatem discusses tesamorelin and his view that it can reshape the body without moving the scale. Treat the claims as his own, not settled fact.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
Brian Underwood shares that the Men's Health fall issue starring Drake Maye is on newsstands, with peptides among the topics inside.
Loading…